Bruker BRKR Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Bsi Biospin | $868.5M-6.7% | $878.8M-3.0% | $884.2M— | $908.5M— | $930.7M— | |
| Bsi Calid | $1.25B+8.8% | $1.21B+10.7% | $1.2B— | $1.17B— | $1.15B— | |
| Bsi Nano | $1.07B-3.7% | $1.08B-1.3% | $1.09B— | $1.11B— | $1.11B— | |
| Energy And Supercon Technologies | $278.4M+3.4% | $270.9M-4.3% | $271.5M-5.1% | $266.4M-7.5% | $269.2M-7.7% | |
| Revenue by Product | ||||||
| Product And Service Other | $689M+9.3% | $670.1M+10.4% | $661.2M+15.0% | $646.9M+18.2% | $630.5M+20.4% | |
| Product | $2.77B-1.6% | $2.77B+0.3% | $2.78B+4.2% | $2.8B+8.7% | $2.82B+13.7% | |
| Revenue by Geography | ||||||
| Asia Pacific Excluding China | $555.9M+2.4% | $552.6M+6.6% | $553.7M+17.9% | $564.1M+27.1% | $542.9M+19.9% | |
| CN | $448.6M-1.8% | $475.8M+1.0% | $451.5M-14.0% | $451M-16.5% | $456.7M-14.8% | |
| DE | $298.6M-2.1% | $297M-4.4% | $277.6M-8.7% | $280.6M-8.8% | $305M+6.8% | |
| Europe Excluding Germany | $985M+7.2% | $950.2M+8.8% | $965.7M+26.9% | $940.1M+30.5% | $919M+30.7% | |
| Other Country | $274.6M+5.0% | $269.6M+5.9% | $263.1M+5.7% | $266.7M+17.9% | $261.4M+14.5% | |
| US | $895.8M-6.8% | $891.3M-5.0% | $927.3M+4.2% | $940.3M+9.1% | $961.1M+20.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Bruker break its business down?
- Bruker (BRKR) reports revenue by business across 4 parts — Bsi Biospin, Bsi Calid, Bsi Nano and Energy And Supercon Technologies. Each is extracted from the segment footnotes and tracked over time.
- Where does Bruker's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bruker's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
